A prospective 10 year follow up study of patients with neurofibromatosis type 1

被引:77
作者
Cnossen, MH [1 ]
de Goede-Bolder, A
van den Broek, KM
Waasdorp, CME
Oranje, AP
Stroink, H
Simonsz, HJ
van den Ouweland, AMW
Halley, DJJ
Niermeijer, MF
机构
[1] Univ Rotterdam Hosp, Hosp Sophia Dijkzigt, Dept Paediat, NL-3015 GJ Rotterdam, Netherlands
[2] Erasmus Univ, NL-3015 GJ Rotterdam, Netherlands
[3] Univ Hosp Sophia Dijkzigt, Dept Clin Genet, Rotterdam, Netherlands
[4] Univ Hosp Sophia Dijkzigt, Dept Dermatol & Venerol, Rotterdam, Netherlands
[5] Univ Hosp Sophia Dijkzigt, Dept Paediat Neurol, Rotterdam, Netherlands
[6] Univ Hosp Sophia Dijkzigt, Dept Ophthalmol, Rotterdam, Netherlands
关键词
neurofibromatosis type 1; genetic disorders;
D O I
10.1136/adc.78.5.408
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective-To establish the prevalence and incidence of symptoms and complications in children with neurofibromatosis type 1 (NF1) and to assess possible risk factors for the development of complications. Design-A 10 year prospective multidisciplinary follow up study. Patients-One hundred and fifty children diagnosed with NF1 according to criteria set by the National Institutes of Health. Results-In 62 of 150 children (41.3%) complications were present, including 42 (28.0%) children with one complication, 18 (12.0%) with two complications, and two (1.3%) with three complications (mean (SD) duration of follow up 4.9 (3.8) years). Ninety five of the 150 children presented without complications (follow up, 340.8 person-years). The incidence of complications was 2.4/100 person-years in this group. An association was found between behavioural problems and the presence of complications. Conclusion-This is the largest single centre case series of NF1 affected children followed until 18 years of age. Children with NF1, including those initially presenting without complications, should have regular clinical examinations.
引用
收藏
页码:408 / 412
页数:5
相关论文
共 13 条
[1]  
[Anonymous], 1988, NEUROFIBROMATOSIS, V1, P172
[2]  
ARON AM, 1990, NEUROFIBROMATOSIS HD
[3]   Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1 [J].
Cnossen, MH ;
Stam, EN ;
Cooiman, LCMG ;
Simonsz, HJ ;
Stroink, H ;
Oranje, AP ;
Halley, DJJ ;
deGoedeBolder, A ;
Niermeijer, MF ;
KeizerSchrama, SMPFD .
PEDIATRICS, 1997, 100 (04) :667-670
[4]  
CNOSSEN MH, IN PRESS J MED GENET
[5]  
COHEN ME, 1988, CHILDS BRAIN, V10, P99
[6]  
HOFMAN KJ, 1994, J PEDIATR, V124, P1
[7]  
Huson S. M., 1994, NEUROFIBROMATOSES PA
[8]   A GENETIC-STUDY OF VONRECKLINGHAUSEN NEUROFIBROMATOSIS IN SOUTH EAST WALES .1. PREVALENCE, FITNESS, MUTATION-RATE, AND EFFECT OF PARENTAL TRANSMISSION ON SEVERITY [J].
HUSON, SM ;
COMPSTON, DAS ;
CLARK, P ;
HARPER, PS .
JOURNAL OF MEDICAL GENETICS, 1989, 26 (11) :704-711
[9]   A GENETIC-STUDY OF VONRECKLINGHAUSEN NEUROFIBROMATOSIS IN SOUTH EAST WALES .2. GUIDELINES FOR GENETIC-COUNSELING [J].
HUSON, SM ;
COMPSTON, DAS ;
HARPER, PS .
JOURNAL OF MEDICAL GENETICS, 1989, 26 (11) :712-721
[10]   NATURAL-HISTORY OF OPTIC PATHWAY TUMORS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-I - A LONGITUDINAL-STUDY [J].
LISTERNICK, R ;
CHARROW, J ;
GREENWALD, M ;
METS, M .
JOURNAL OF PEDIATRICS, 1994, 125 (01) :63-66